Immunotoxins are protein molecules composed of monoclonal antibodies linked covalently to either peptide toxins or polypeptides related to toxins. These molecules can be used in the therapy of a number of malignant diseases including lymphoma, leukemia, and solid tumors. They can be used to prevent graft-versus-host disease or rejection in transplanted organs, such as bone marrow and pancreas. The design and development of these molecules, as well as a clinical development plan, will be discussed.
|Original language||English (US)|
|Number of pages||10|
|Journal||Journal of Biological Response Modifiers|
|State||Published - Oct 1985|
ASJC Scopus subject areas
- Cancer Research